One of Alzheimer’s disease’s key players, beta-amyloid presents a complex picture. If you or a loved one is going through the diagnostic process for…
A new study reveals that Asian, Black, and Hispanic patients are less likely to develop beta-amyloid plaques — a key Alzheimer’s biomarker — alongside…
Here’s a theory: Alzheimer’s biomarker beta-amyloid could — rather than killing the brain — actually be trying to defend it. The provocative idea builds on…
The SYNTap Test, a new biomarker test to help diagnose diseases like Parkinson’s, Lewy body dementia and Multiple System Atrophy, is now on the…
Scientists have made strides in improving the precision of diagnosing Alzheimer’s, but available diagnostic tools that measure Alzheimer’s biomarkers remain inaccessible for many patients….
Data on Cassava Sciences’ Alzheimer’s drug candidate, simufilam, found it was not only safe, but modified disease biomarkers at six months, and improved cognition…
New research suggests that certain Alzheimer’s blood biomarkers are associated with neurological symptoms of COVID-19 and older adults infected with SARS-CoV-2, the virus that…